ALG.APV-527

N/A

Report date: 2024/05/30 18:03:03

Base Information

Drug NameALG.APV-527
Drug Alias Name4-1BB x 5T4 ADAPTIR™ Bispecific AntibodyADC-1016ATOR-1016ALG.APV-527ALG-APV-527 +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsTrophoblast glycoprotein modulators
TargetsTumor necrosis factor receptor superfamily member 9Trophoblast glycoprotein
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlligator Bioscience AbAptevo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlligator Bioscience AbAptevo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A